Previous Article | Next Article ![]()
Infection and Immunity, July 2000, p. 3900-3908, Vol. 68, No. 7
Department of Microbiology and Immunology, University of
Kentucky College of Medicine, Lexington, Kentucky
40536-0298,1 and Laboratory of
Human Bacterial Pathogenesis2 and
Microscopy Branch,3 Rocky Mountain
Laboratories, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, Hamilton, Montana 59840
Received 27 January 2000/Returned for modification 21 March
2000/Accepted 7 April 2000
Borrelia hermsii, an agent of tick-borne relapsing
fever, was found to contain multiple circular plasmids approximately 30 kb in size. Sequencing of a DNA library constructed from circular plasmid fragments enabled assembly of a composite DNA sequence that is
homologous to the cp32 plasmid family of the Lyme disease spirochete,
B. burgdorferi. Analysis of another relapsing fever bacterium, B. parkeri, indicated that it contains linear
homologs of the B. hermsii and B. burgdorferi
cp32 plasmids. The B. hermsii cp32 plasmids encode homologs
of the B. burgdorferi Mlp and Bdr antigenic proteins and
BlyA/BlyB putative hemolysins, but homologs of B. burgdorferi
erp genes were absent. Immunoblot analyses demonstrated that
relapsing fever patients produced antibodies to Mlp proteins, indicating that those proteins are synthesized by the spirochetes during human infection. Conservation of cp32-encoded genes in different
Borrelia species suggests that their protein products serve
functions essential to both relapsing fever and Lyme disease spirochetes. Relapsing fever borreliae replicate to high levels in the
blood of infected animals, permitting direct detection and possible
functional studies of Mlp, Bdr, BlyA/BlyB, and other cp32-encoded
proteins in vivo.
The spirochete genus
Borrelia contains many important pathogens of humans and
domestic animals, including the causative agents of Lyme disease
(the Borrelia burgdorferi sensu lato group) and tick-borne
relapsing fever (B. hermsii, B. duttonii,
B. parkeri, B. turicatae, and others)
(43). Also within this genus are B. anserina (the
agent of avian borreliosis), B. recurrentis (the agent of
human louse-borne relapsing fever), B. coriaceae (the putative, yet unproven, agent of epizootic bovine abortion), and several other species of unknown pathogenic significance
(43). All Borrelia species persist in nature
through cycles requiring humans or wild animals and blood-feeding
arthropods as hosts (9, 41, 43).
Both tick-borne relapsing fever and Lyme disease borreliae infect their
vectors during ingestion of blood and then migrate to the salivary
glands to be transmitted via the saliva as the tick feeds on a new
vertebrate host. The tick-borne relapsing fever spirochete B. hermsii is transmitted by the argasid tick Ornithodoros
hermsi, a relatively fast feeder that usually takes in a complete
blood meal in less than 1 h (49). B. hermsii
replicates to high levels in the blood of infected mammals, presumably
as an adaptation to ensure acquisition by the rapidly feeding tick vectors. Relapsing fever borreliae persistently infect tick salivary glands prior to vector feeding, another adaptation that enhances transmission during the brief period the tick remains attached to its
vertebrate host (43). In contrast, Lyme disease spirochetes are transmitted by the bites of ixodid ticks, which attach to their
hosts and feed for several days (49). Probably as
adaptations to these slow-feeding vectors, B. burgdorferi
does not produce high levels of spirochetemia and is generally
difficult to observe in host blood samples. The bacteria are generally
restricted to the midgut of unfed infected ticks and are found in the
tick salivary glands only transiently during vector feeding
(43).
Despite these differences, relapsing fever and Lyme disease spirochetes
appear to use homologous proteins to facilitate interactions with their
arthropod and mammalian hosts. During tick feeding, B. burgdorferi increases production of the surface-exposed
lipoprotein OspC (16, 17, 23, 25, 30, 45, 46). After
ingestion by its tick vector, B. hermsii increases synthesis
of a membrane-bound lipoprotein, Vsp33 (also called VmpC)
(44), that is homologous to OspC of B. burgdorferi (31, 32, 59), and this protein continues to
be made during persistent infection of the tick salivary glands
(44). These observations suggest that OspC and Vsp33 are
required by their respective bacteria for either infecting the salivary
glands or infecting mammalian hosts immediately following their
transmission by tick bite. During mammalian infection, relapsing fever
spirochetes produce additional surface proteins (Vsps or Vlps), the
genes for which vary through intergenic recombination mechanisms
(5, 55), and B. burgdorferi has recently been found to contain a homologous locus (vlsE) that also
undergoes genetic recombination during mammalian infection
(62). These reports suggest that other genetic similarities
might exist between the relapsing fever and Lyme disease spirochetes.
Both B. hermsii and B. burgdorferi carry numerous
extrachromosomal elements (7, 14, 27, 42, 60). B. burgdorferi and all other Lyme disease spirochetes examined
contain members of a circular plasmid family designated cp32 (1,
3, 13, 15, 37, 52, 54). Individual B. burgdorferi that
contain as many as nine different cp32s, which are homologous through most of their DNA sequences, have been identified. The cp32s generally have circumferences of 30 to 32 kb (14, 15, 54), although variants that are approximately 18 kb (10, 37, 52) or as small as 8 to 10 kb in size (19, 24) have been found; a
linear 56-kb plasmid containing an entire cp32 has also been
characterized (14, 15, 63). The larger B. burgdorferi cp32s encode several antigenic proteins, including
members of the Erp, Mlp, and Bdr protein families (S. Porcella,
unpublished results; 14, 15, 28, 34, 37, 50, 52, 54, 61, 63,
64), as well as two putative hemolysins, BlyA and BlyB
(14, 26, 37). In our studies of B. hermsii,
we found that these relapsing fever spirochetes contain multiple
circular plasmids that are homologous to the B. burgdorferi
cp32s and encode similar proteins synthesized during mammalian
infection, suggesting conserved infection mechanisms among different
species of the genus Borrelia. These similarities provide
the foundation for future studies comparing cp32-encoded proteins of
both the relapsing fever and Lyme disease spirochetes during their
alternating infections of mammals and ticks.
Bacteria.
B. hermsii isolate HS1, the type strain of
the species, was isolated from an O. hermsii tick collected
near Spokane, Wash. (57), and has been cloned by limiting
dilution (55). B. hermsii isolates DAH, FRO, HAN,
MAN, CON, and YOR were all isolated in the western United States from
human blood (27). The HS1 and DAH isolates are genetically
indistinguishable at every locus examined previously (27).
B. burgdorferi isolate B31-4a was derived from a single
colony grown in solid medium (15). Isolates of B. parkeri and B. anserina have been described previously
(27). All Borrelia species were grown at 35°C
in either Barbour-Stoener-Kelly (BSK)-II (6) or BSK-H
(Sigma, St. Louis, Mo.), supplemented with 6% rabbit serum (Sigma).
B. hermsii circular plasmid library construction and
analysis.
Supercoiled circular plasmids were purified from
B. hermsii isolate HS1 by cesium chloride gradient
centrifugation (48). Purified circular DNA was digested with
EcoRI and cloned into pUC13 (Bethesda Research Laboratories,
Gaithersburg, Md.) to produce a B. hermsii circular plasmid
library. Recombinant plasmids pSPR61, pSPR63, pSPR66, pSPR67, and
pSPR71 were purified from Escherichia coli using Qiagen Midi
kits (Qiagen, Santa Clarita, Calif.).
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The Relapsing Fever Spirochete Borrelia hermsii
Contains Multiple, Antigen-Encoding Circular Plasmids That Are
Homologous to the cp32 Plasmids of Lyme Disease
Spirochetes

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
PCR analysis of B. hermsii circular plasmids. Cloned fragments of B. hermsii cp32s were linked by PCR of genomic HS1 DNA. Reaction conditions for short amplifications (less than 2 kb) consisted of 25 cycles of 94°C for 30 s, 50°C for 30 s, and extension at 65°C for 2 min. PCR amplifications for fragments greater than 5 kb were performed using the Expand Long Template PCR system (Boehringer Mannheim, Indianapolis, Ind.) with 10 cycles of 94°C for 10 s, 50°C for 30 s, and 68°C for 10 min, followed by 20 cycles with the time of each successive extension step increasing by 20 s.
Southern blot analysis. DNA molecules of different sizes were separated by pulsed-field agarose gel electrophoresis or two-dimensional chloroquine agarose gel electrophoresis and transferred to nylon membranes as previously described (54). Membranes were incubated overnight with radiolabeled probes at either 55°C (high stringency) or 45°C (low stringency) (22). Blots were washed in either 0.2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.1% sodium dodecyl sulfate (SDS) at 55°C (high-stringency wash conditions) or 2× SSC-0.1% SDS at room temperature (low-stringency wash conditions). Hybridized probes were visualized by autoradiography.
Probes for Southern blotting were produced by PCR (54) from appropriate recombinant plasmid clones using oligonucleotides listed in Table 1. Three different B. hermsii cp32 probes were produced using pSPR67 as template. Two probes, one derived from the B. burgdorferi B31 erpK promoter region (22) and one from an internal region of B31 erpM that is almost entirely composed of GAA and AAA codons, were produced from plasmids pBLS491 and pBLS492, respectively (15, 50). Probes were purified by dilution in 2 ml of water and concentrated to a final volume of approximately 60 µl in Centricon-100 spin columns (Amicon, Beverly, Mass.) (54). Purified probes were labeled with [
-32P]dATP (DuPont,
Boston, Mass.) by random priming (Life Technologies, Gaithersburg,
Md.).
|
Recombinant Mlp proteins and immunoblot analyses. Polyhistidine-tagged recombinant MlpL and MlpK proteins were synthesized as follows. The mlpL and partial mlpK genes were PCR amplified from pSPR67 and pSPR66, respectively, ligated into plasmid pET-15b (Novagen, Madison, Wis.), and transformed into E. coli BL21(DE3) (Novagen). Recombinant MlpL and MlpK proteins were expressed and purified as specified by the manufacturer (Novagen). Purified proteins were quantified using the Bio-Rad (Hercules, Calif.) protein assay, and approximately 10 µg of each protein was subjected to polyacrylamide gel electrophoresis and transferred to Hybond-P polyvinylidene difluoride membranes (Amersham, Little Chalfont, England). Membranes were blocked for 2 h in phosphate-buffered saline-Tween 20 (PBS-T; 100 mM sodium phosphate, 100 mM NaCl, 0.1% [vol/vol] Tween 20) containing 5% nonfat dry milk. Membranes were then incubated for 1 h with a 1:200 diluted serum sample from either a human patient diagnosed with relapsing fever or an uninfected individual, washed thoroughly with PBS-T, and incubated for 1 h with anti-human immunoglobulin-horseradish peroxidase conjugate (diluted 1:20,000; Amersham). Bound secondary antibody was detected by enhanced chemiluminescence (Amersham). Serum samples from 10 clinically diagnosed relapsing fever patients and 19 uninfected humans were generously provided by Donald Anderson (Sacred Heart Medical Center, Spokane, Wash.) and Martin Schriefer and David Dennis (Centers for Disease Control and Prevention, Fort Collins, Colo.).
Nucleotide sequence accession numbers. The sequences of the inserts of pSPR61-L, pSPR61-R, pSPR63, pSPR66, pSPR67, and pSPR71 have been submitted to GenBank and given accession numbers AF209439, AF209440, AF209441, AF209442, AF123078, and AF209443, respectively. The sequences of the EcoRI- and BamHI-digested fragments of PCR#1 have accession numbers AF209444 through AF209449. The sequence of PCR#2 has accession number AF209450. Annotated sequence of the composite B. hermsii cp32 illustrated in Fig. 3 is available from http://jenner.mi.uky.edu/bstevens/Bhcp32.htm.
| |
RESULTS |
|---|
|
|
|---|
Characterization of B. hermsii circular plasmids.
Two-dimensional agarose gel analysis of total DNA preparations from
several isolates of B. hermsii demonstrated some DNA
molecules that migrated more slowly in the second dimension after
treatment (Fig. 1), indicating they were
supercoiled in structure (40, 54). Electron microscopy (EM)
analysis of spread DNA samples from these same isolates all showed
circular molecules estimated to be 28 to 30 kb in size (data not
shown). However, EcoRI digestion analysis of purified
circular DNA showed that the fragment sizes added up to significantly
more than the size based on EM analysis (Fig.
2). Therefore, we suspected that the
population of 28- to 30-kb circular plasmids was comprised of multiple
similar-sized molecules that varied in sequence.
|
|
|
|
B. hermsii plasmids encode antigenic proteins homologous to proteins of B. burgdorferi. Humans and other mammals infected with B. burgdorferi produce antibodies directed against the Mlp (Porcella, unpublished; 61) and Bdr (64) proteins, indicating that those proteins are synthesized during mammalian infection. Additionally, the B. burgdorferi cp32 blyA and blyB genes encode putative hemolytic proteins (26). Sequencing of the cloned B. hermsii cp32 fragments indicated that isolate HS1 contained at least two mlp genes (mlpK and mlpL, cloned in recombinant plasmids pSPR66 and pSPR67, respectively), two bdr genes (bdrA and bdrB), and a blyAB locus.
The sequences of B. burgdorferi mlp paralogs can vary considerably between different bacteria (14, 37, 61), and our sequencing data indicated that this was also true of the B. hermsii paralogs. The B. hermsii mlpK and mlpL genes were identified on different, overlapping cloned cp32 fragments, and the deduced MlpK and MlpL proteins share approximately 48% identical amino acids. Compared to the B. burgdorferi B31 proteins, MlpK was most similar to B31 MlpF (located on cp32-6, 58% identity) and MlpL was most similar to B31 MlpB (located on cp32-2, 46% identity) (Fig. 5). Despite sequence variability, borrelial Mlp proteins fall into two classes based on size, hydrophilicity profiles, and antigenic cross-reactivity (37, 61), with the HS1 MlpK being a member of class 2 and MlpL being a member of class 1.
|
|
Other ORFs found on both B. burgdorferi and B. hermsii cp32s. Alignment of the composite B. hermsii cp32 with a typical B. burgdorferi cp32 indicated extensive regions of homology between the two species (Fig. 3). Many of the ORFs on the B. hermsii cp32 are also in the same relative position and orientation on B. burgdorferi cp32s, although the DNA sequences of the two species are not identical. For example, a pair of oligonucleotide primers directs PCR amplification of a region spanning the PF-115 and PF-145 loci (52) of all Lyme disease spirochetes and has been used in differentiating these bacteria from other Borrelia species (3). As expected, the corresponding regions of the B. hermsii cp32 fragments cloned in pSPR6 and pSPR67 lack both oligonucleotide binding sites.
The B. hermsii and B. burgdorferi cp32s also differ in having opposite orientations for the five-gene cluster spanning PF-57 through the adjacent bdr allele (Fig. 3). Unlike all known members of the B. burgdorferi cp32 family (14, 19, 24, 52, 63), the B. hermsii PF-57-to-bdr regions are not flanked by inverted repeats, nor do the immediately flanking sequences resemble those of B. burgdorferi cp32s. An earlier study, using high-stringency Southern blotting with probes derived from cp32s of B. burgdorferi isolate Sh-2-82, indicated hybridization with DNA from Lyme disease spirochetes but not from B. hermsii (48). Sequencing of the B. burgdorferi Sh-2-82 DNA fragments revealed that they were derived from the bdr-to-erp regions of two different cp32s (pSPR13 and pSPR14) and from a cp32 PF-147-to-PF-108 region (pSPR9) (data not shown). These regions of B. hermsii and B. burgdorferi cp32s share an average 60% or less identical nucleotides with interspersed unrelated sequences, differences that apparently prevented hybridization between the two species' DNAs under the conditions used in the earlier studies (48).Novel ORFs on B. hermsii cp32. The cp32 fragment cloned in recombinant plasmid pSPR67 contained three ORFs unrelated to any sequences on B. burgdorferi cp32 plasmids (Fig. 3). One, designated bhm (B. hermsii methyltransferase), encodes a protein homologous to the BalI methylase of Brevibacterium albidum and the StsI methylase of Streptococcus sanguis (GenBank accession numbers D82028 and D11101, respectively). The predicted Bhm protein bears little similarity to the putative nucleotide methylases on the lp56 and lp25 plasmids of B. burgdorferi (14, 24). A second unique ORF, ssb, is homologous to genes encoding single-stranded DNA binding proteins found on the chromosomes of B. burgdorferi (24) and many other bacteria. None of the B. burgdorferi plasmids contain ssb homologs (14, 24), but similar ssb genes are found on the E. coli plasmid R64 and related conjugative plasmids (38). A third ORF, ORF-Z, is not related to any gene or protein previously reported to GenBank.
Homologs of B. hermsii cp32s in other relapsing fever
spirochetes.
Having found multiple cp32 plasmids in both B. hermsii and B. burgdorferi, we examined isolates of
other Borrelia species for cp32-related plasmids. DNA from
B. parkeri and B. anserina were digested,
blotted, and hybridized with the B. hermsii cp32 PF-144
probe. At low stringency, this probe hybridized with multiple DNA
fragments from both B. parkeri and B. burgdorferi, although not with any DNA from B. anserina
(Fig. 7A). Hybridization of the PF-144
probe with B. parkeri DNA separated by two-dimensional gel
electrophoresis indicated the presence of related linear DNA in that
species but no circular forms (Fig. 7B). During the course of our work,
others reported that a probe derived from a B. turicatae bdr
homolog also hybridized with multiple fragments of B. parkeri DNA (11, 12). These data indicate that B. parkeri contains multiple plasmids related to the B. hermsii and B. burgdorferi cp32 plasmids, although all
such plasmids appear to be linear. The isolate of B. anserina used in our studies does not appear to contain
cp32-related plasmids, although it may contain DNAs with sequences too
divergent from those of B. hermsii for our detection.
|
| |
DISCUSSION |
|---|
|
|
|---|
We found that B. hermsii HS1 contains circular plasmids that by EM contour length measurement had sizes of approximately 30 kb. Fragments of these plasmids were linked by overlapping sequences to assemble a composite circular DNA sequence of 30,295 bp in circumference, with extensive homology to the cp32 family of B. burgdorferi plasmids. Sequencing of B. hermsii HS1 cp32 fragments indicated that these clonal bacteria contain at least two different cp32s, while Southern blotting suggested four or more such plasmids in this strain. The five other B. hermsii isolates examined also contain multiple cp32s. Two other species of relapsing fever spirochetes, B. parkeri and B. turicatae, also contain linear DNAs related to the B. hermsii and B. burgdorferi cp32 plasmids (this work and references 11 and 12).
Comparison of the ORFs found on the B. hermsii cp32 DNAs with those on B. burgdorferi cp32s revealed the presence of homologous genes in the two species, including members of the mlp, bdr, and blyAB gene families. These similarities suggest common functions for cp32-encoded proteins in the different Borrelia species. Furthermore, the presence of similar genes in both B. hermsii and B. burgdorferi presents opportunities to compare protein synthesis patterns and functions in the two species of bacteria during mammalian and tick infections. For example, the Mlp proteins of both B. hermsii and B. burgdorferi are synthesized in vivo, as indicated by the reactivity against recombinant Mlps with serum samples from both relapsing fever (this work) and Lyme disease patients (Porcella, unpublished; 61). Since B. hermsii achieves high levels of bacteremia in the mammalian bloodstream, spirochetes can be examined directly in blood smears from infected animals. Future studies can determine the time course of Mlp synthesis in both mammals and ticks, which of the Mlp proteins are produced, and the location of Mlps in the bacterial cell. Similar in vivo studies on the synthesis and function of the Bdr antigens, BlyA/BlyB putative hemolysins, and other cp32-encoded proteins conserved in relapsing fever Borrelia species can also be performed.
All analyzed Lyme disease spirochete cp32s contain erp genes, which encode antigenic proteins synthesized during the initial stages of mammalian infection (2, 28, 50, 53, 56, 58). However, no such gene was found on B. hermsii cp32s, nor was there hybridization evidence of erp genes elsewhere in the B. hermsii genome. These data suggest that Erp proteins perform functions essential for Lyme disease borrelial infection that are not required by relapsing fever borreliae. Additional analyses of B. hermsii and other spirochetes of this genus will undoubtedly reveal additional differences reflecting the distinct life histories of Borrelia species.
The B. hermsii cp32 fragments cloned in recombinant plasmids pSPR66 and pSPR67 contained similar sequences, although differences were found throughout the two plasmid inserts, with regions of near identity separated by regions without recognizable similarity. The B. hermsii cp32 fragment cloned in pSPR66 appears to be badly damaged, since its PF-115 and PF-145 ORFs contain multiple frameshifts and premature termination codons, suggesting that the products of PF-115 and PF-145 are not essential for B. hermsii cp32 maintenance. Further comparative studies will identify whether the DNA near the B. hermsii cp32 mlp locus is a hot spot for mutation and recombination. Additionally, the apparent mutations in the cp32 fragment cloned in pSPR66 may indicate that relapsing fever spirochetes harbor degenerated plasmids, as do the Lyme disease borreliae (14).
Phage-like particles have been observed in B. hermsii cultures (9), and since there is evidence that B. burgdorferi cp32s may be bacteriophage genomes (14, 21), B. hermsii cp32s might also be prophages. That hypothesis is further supported by the presence of the B. hermsii cp32 ssb gene, since bacteriophages often encode single-stranded DNA binding proteins (29). Such bacteriophages may be capable of transferring DNA between B. hermsii and thus prove to be useful genetic tools.
The B. hermsii composite cp32 contains an additional novel gene, bhm, encoding a putative nucleotide methylase. Earlier reports indicated the presence of methylated DNA in B. hermsii and other relapsing fever spirochetes (33, 35), possibly consequences of the bhm gene product. The presence of a nucleotide methylase in these bacteria may indicate a DNA restriction mechanism, which could have important consequences on the development of a B. hermsii recombinant genetic system. DNA methylation can play other roles in prokaryotes, including gene regulation and the packaging of bacteriophage DNA into capsids (36). Nucleotide methylases may also protect bacteria from toxic substances, such as modifying rRNA to mediate resistance to macrolide antibiotics (18).
Based on their location on almost all borrelial plasmids and homologies with plasmid proteins of other bacterial species, the proteins of paralog families 57, 50, 32, and 49 have been proposed to be involved with plasmid replication and partition (8, 14, 19, 51, 63). Sequencing and hybridization studies indicate that plasmids of different B. burgdorferi isolates often contain nearly identical PF-32 and PF-49 gene pairs (R. Iyer, O. Kalu, I. Schwartz, and B. Stevenson, Abstr. 99th Gen. Meet. Am. Soc. Microbiol., abstr. D/B-260, 1999; 10, 51), suggesting that the products of these two genes specifically interact with each other. Additionally, all cp32s in individual B. burgdorferi encode PF-32 and PF-49 proteins with no more than 65% identical amino acids (51), which may account for the compatibility of the different plasmids. The PF-32 and PF-49 proteins encoded by the pSPR61-L B. hermsii cp32 fragment share 76 and 75% identical amino acids with their B. burgdorferi B31 cp32-6 homologs but less than 65% identity with proteins encoded by the other B31 cp32s. The similarity of the B. hermsii cp32 and B. burgdorferi cp32-6 putative segregation genes raises the intriguing possibility that these two plasmids are more closely related to each other than are most of the B. burgdorferi B31 cp32s. This implies that either B. hermsii and B. burgdorferi have exchanged DNA at some time or the divergence of cp32s predated the divergence of the relapsing fever and Lyme disease borreliae from their common ancestor.
Many species within the genus Borrelia contain multiple plasmids of the cp32 family (this work and references 11, 12, 15, 37, 54, and 63). The cp32 plasmids of B. hermsii and B. burgdorferi contain many homologous genes, most of which are located in similar positions and orientations. This conservation of sequences indicates that they serve important functions, either for survival of the bacteria or for maintenance of the plasmids. Production of conserved proteins during mammalian infection also implies essential functions, perhaps facilitating interactions with tissues of the mammalian or arthropod hosts. We propose that comparative studies of cp32-encoded proteins of B. hermsii and B. burgdorferi will help elucidate the mechanisms underlying the pathogenicity of these bacteria.
| |
ACKNOWLEDGMENTS |
|---|
This study was funded in part by grants RO1-AI44254 from the National Institutes of Health and 949 from the University of Kentucky Chandler Medical Center Research Fund to Brian Stevenson.
Stephen Porcella and Brian Stevenson contributed equally to the work described in this report.
We thank Donald Anderson, Jr., Martin Schriefer, and David Dennis for providing sera, Lou Lieto for technical assistance, Patti Rosa for helpful encouragement, and Sherwood Casjens and Wolf Zückert for valuable discussions and for constructive comments on the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Department of Microbiology and Immunology, MS 415 Chandler Medical Center, University of Kentucky College of Medicine, Lexington, KY 40536-0298. Phone: (859) 257-9358. Fax: (859) 257-8994. E-mail: bstev0{at}pop.uky.edu.
Present address: Department of Microbiology, Duke University
Medical Center, Durham, NC 27710.
Editor: D. L. Burns
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Akins, D. R.,
M. J. Caimano,
X. Yang,
F. Cerna,
M. V. Norgard, and J. D. Radolf.
1999.
Molecular and evolutionary analysis of Borrelia burgdorferi 297 circular plasmid-encoded lipoproteins with OspE- and OspF-like leader peptides.
Infect. Immun.
67:1526-1532 |
| 2. | Akins, D. R., S. F. Porcella, T. G. Popova, D. Shevchenko, S. I. Baker, M. Li, M. V. Norgard, and J. D. Radolf. 1995. Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue. Mol. Microbiol. 18:507-520[CrossRef][Medline]. |
| 3. | Amouriaux, P., M. Assous, D. Margarita, G. Baranton, and I. Saint Girons. 1993. Polymerase chain reaction with the 30-kb circular plasmid of Borrelia burgdorferi B31 as a target for detection of the Lyme borreliosis agents in cerebrospinal fluid. Res. Microbiol. 144:211-219[Medline]. |
| 4. |
Banerjee, S. N.,
M. Banerjee,
K. Fernando,
W. Burgdorfer, and T. G. Schwan.
1998.
Tick-borne relapsing fever in British Columbia, Canada: first isolation of Borrelia hermsii.
J. Clin. Microbiol.
36:3505-3508 |
| 5. | Barbour, A. G. 1990. Antigenic variation of a relapsing fever Borrelia species. Annu. Rev. Microbiol. 44:155-171[CrossRef][Medline]. |
| 6. | Barbour, A. G. 1984. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57:521-525[Medline]. |
| 7. |
Barbour, A. G.
1988.
Plasmid analysis of Borrelia burgdorferi, the Lyme disease agent.
J. Clin. Microbiol.
26:475-478 |
| 8. |
Barbour, A. G.,
C. J. Carter,
V. Bundoc, and J. Hinnebusch.
1996.
The nucleotide sequence of a linear plasmid of Borrelia burgdorferi reveals similarities to those of circular plasmids of other prokaryotes.
J. Bacteriol.
178:6635-6639 |
| 9. |
Barbour, A. G., and S. F. Hayes.
1986.
Biology of Borrelia species.
Microbiol. Rev.
50:381-400 |
| 10. |
Caimano, M. J.,
X. Yang,
T. G. Popova,
M. L. Clawson,
D. R. Akins,
M. V. Norgard, and J. D. Radolf.
2000.
Molecular and evolutionary characterization of the cp32/18 family of supercoiled plasmids in Borrelia burgdorferi 297.
Infect. Immun.
68:1574-1586 |
| 11. |
Carlyon, J. A., and R. T. Marconi.
1998.
Cloning and molecular characterization of a multicopy, linear plasmid-carried, repeat motif-containing gene from Borrelia turicatae, a causative agent of relapsing fever.
J. Bacteriol.
180:4974-4981 |
| 12. | Carlyon, J. A., D. M. Roberts, and R. T. Marconi. 2000. Evolutionary and molecular analyses of the Borrelia bdr super gene family: delineation of distinct sub-families and demonstration of the genus wide conservation of putative functional domains, structural properties and repeat motifs. Microb. Pathog. 28:89-105[CrossRef][Medline]. |
| 13. | Casjens, S., and W. M. Huang. 1993. Linear chromosomal physical and genetic map of Borrelia burgdorferi, the Lyme disease agent. Mol. Microbiol. 8:967-980[CrossRef][Medline]. |
| 14. | Casjens, S., N. Palmer, R. van Vugt, W. M. Huang, B. Stevenson, P. Rosa, R. Lathigra, G. Sutton, J. Peterson, R. J. Dodson, D. Haft, E. Hickey, M. Gwinn, O. White, and C. Fraser. 2000. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs of an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 35:490-516[CrossRef][Medline]. |
| 15. |
Casjens, S.,
R. van Vugt,
K. Tilly,
P. A. Rosa, and B. Stevenson.
1997.
Homology throughout the multiple 32-kilobase circular plasmids present in Lyme disease spirochetes.
J. Bacteriol.
179:217-227 |
| 16. | Coleman, J. L., J. A. Gebbia, J. Piesman, J. L. Degen, T. H. Bugge, and J. L. Benach. 1997. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 89:1111-1119[CrossRef][Medline]. |
| 17. |
de Silva, A. M.,
S. R. Telford,
L. R. Brunet,
S. W. Barthold, and E. Fikrig.
1996.
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
J. Exp. Med.
183:271-275 |
| 18. |
Dowding, J., and J. Davies.
1975.
Mechanisms and origins of plasmid-determined antibiotic resistance, p. 179-186.
In
D. Schlessinger (ed.), Microbiology 1974. American Society for Microbiology, Washington, D.C.
|
| 19. |
Dunn, J. J.,
S. R. Buchstein,
L.-L. Butler,
S. Fisenne,
D. S. Polin,
B. N. Lade, and B. J. Luft.
1994.
Complete nucleotide sequence of a circular plasmid from the Lyme disease spirochete, Borrelia burgdorferi.
J. Bacteriol.
176:2706-2717 |
| 20. | Dworkin, M. S., D. E. Anderson, T. G. Schwan, P. C. Shoemaker, S. N. Banerjee, B. O. Kassen, and W. Burgdorfer. 1998. Tick-borne relapsing fever in the northwestern United States and southwestern Canada. Clin. Infect. Dis. 26:122-131[Medline]. |
| 21. |
Eggers, C. H., and D. S. Samuels.
1999.
Molecular evidence for a new bacteriophage of Borrelia burgdorferi.
J. Bacteriol.
181:7308-7313 |
| 22. |
El-Hage, N.,
L. D. Lieto, and B. Stevenson.
1999.
Stability of erp loci during Borrelia burgdorferi infection: recombination is not required for chronic infection of immunocompetent mice.
Infect. Immun.
67:3146-3150 |
| 23. | Fingerle, V., G. Liegl, U. Munderloh, and B. Wilske. 1998. Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus ticks removed from humans. Med. Microbiol. Immunol. 187:121-126[CrossRef][Medline]. |
| 24. | Fraser, C. M., S. Casjens, W. M. Huang, G. G. Sutton, R. Clayton, R. Lathigra, O. White, K. A. Ketchum, R. Dodson, E. K. Hickey, M. Gwinn, B. Dougherty, J.-F. Tomb, R. D. Fleischmann, D. Richardson, J. Peterson, A. R. Kerlavage, J. Quackenbush, S. Salzberg, M. Hanson, R. van Vugt, N. Palmer, M. D. Adams, J. Gocayne, J. Weidmann, T. Utterback, L. Watthey, L. McDonald, P. Artiach, C. Bowman, S. Garland, C. Fujii, M. D. Cotton, K. Horst, K. Roberts, B. Hatch, H. O. Smith, and J. C. Venter. 1997. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580-586[CrossRef][Medline]. |
| 25. |
Gilmore, R. D., and J. Piesman.
2000.
Inhibition of Borrelia burgdorferi migration from the midgut to the salivary glands following feeding by ticks on OspC-immunized mice.
Infect. Immun.
68:411-414 |
| 26. | Guina, T., and D. B. Oliver. 1997. Cloning and analysis of a Borrelia burgdorferi membrane-interactive protein exhibiting haemolytic activity. Mol. Microbiol. 24:1201-1213[CrossRef][Medline]. |
| 27. |
Hinnebusch, B. J.,
A. G. Barbour,
B. I. Restrepo, and T. G. Schwan.
1998.
Population structure of the relapsing fever spirochete Borrelia hermsii as indicated by polymorphism of two multigene families that encode immunogenic outer surface lipoproteins.
Infect. Immun.
66:432-440 |
| 28. |
Lam, T. T.,
T.-P. K. Nguyen,
R. R. Montgomery,
F. S. Kantor,
E. Fikrig, and R. A. Flavell.
1994.
Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease.
Infect. Immun.
62:290-298 |
| 29. |
Lehnherr, H.,
J. D. Bendtsen,
F. Preuss, and T. V. Ilyina.
1999.
Identification and characterization of the single-stranded DNA-binding protein of bacteriophage P1.
J. Bacteriol.
181:6463-6468 |
| 30. | Leuba-Garcia, S., R. Martinez, and L. Gern. 1998. Expression of outer surface proteins A and C of Borrelia afzelii in Ixodes ricinus ticks and in the skin of mice. Zentbl. Bakteriol. 287:475-484. |
| 31. |
Marconi, R. T.,
D. S. Samuels,
T. G. Schwan, and C. T. Garon.
1993.
Identification of a protein in several species of Borrelia related to OspC of the Lyme disease spirochetes.
J. Clin. Microbiol.
31:2577-2583 |
| 32. | Margolis, N., D. Hogan, W. Cieplak, Jr., T. G. Schwan, and P. A. Rosa. 1994. Homology between Borrelia burgdorferi OspC and members of the family of Borrelia hermsii variable major proteins. Gene 143:105-110[CrossRef][Medline]. |
| 33. | Meier, J. T., M. I. Simon, and A. G. Barbour. 1985. Antigenic variation is associated with DNA rearrangements in a relapsing fever Borrelia. Cell 41:403-409[CrossRef][Medline]. |
| 34. |
Miller, J. C.,
N. El-Hage,
K. Babb, and B. Stevenson.
2000.
Borrelia burgdorferi B31 Erp proteins that are dominant immunoblot antigens of animals infected with isolate B31 are recognized by only a subset of human Lyme disease patient sera.
J. Clin. Microbiol.
38:1569-1574 |
| 35. |
Norton Hughes, C. A., and R. C. Johnson.
1990.
Methylated DNA in Borrelia species.
J. Bacteriol.
172:6602-6604 |
| 36. | Noyer-Weidner, M., and T. A. Trautner. 1993. Methylation of DNA in prokaryotes, p. 39-108. In J. P. Jost, and H. P. Saluz (ed.), DNA methylation: molecular biology and biological significance. Birkhäuser Verlag, Basel, Switzerland. |
| 37. |
Porcella, S. F.,
T. G. Popova,
D. R. Akins,
M. Li,
J. D. Radolf, and M. V. Norgard.
1996.
Borrelia burgdorferi supercoiled plasmids encode multicopy tandem open reading frames and a lipoprotein gene family.
J. Bacteriol.
178:3293-3307 |
| 38. | Ruvolo, P. P., K. M. Keating, K. R. Williams, and J. W. Chase. 1991. Single-stranded binding proteins (SSBs) from prokaryotic transmissible plasmids. Proteins 9:120-134[CrossRef][Medline]. |
| 39. | Sambri, V., A. Marangoni, F. Massaria, A. Farencena, M. La Placa, and R. Cevenini. 1995. Functional activities of antibodies directed against surface lipoproteins of Borrelia hermsii. Microbiol. Immunol. 39:623-627[Medline]. |
| 40. |
Samuels, D. S., and C. F. Garon.
1993.
Coumermycin A1 inhibits growth and induces relaxation of supercoiled plasmids in Borrelia burgdorferi, the Lyme disease agent.
Antimicrob. Agents Chemother.
37:46-50 |
| 41. | Schwan, T. G. 1996. Ticks and Borrelia: model systems for investigating pathogen-arthropod interactions. Infect. Agents Dis. 5:167-181[Medline]. |
| 42. |
Schwan, T. G.,
W. Burgdorfer, and C. F. Garon.
1988.
Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.
Infect. Immun.
56:1831-1836 |
| 43. | Schwan, T. G., W. Burgdorfer, and P. A. Rosa. 1999. Borrelia, p. 746-758. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C. |
| 44. |
Schwan, T. G., and B. J. Hinnebusch.
1998.
Bloodstream- versus tick-associated variants of a relapsing fever bacterium.
Science
280:1938-1940 |
| 45. |
Schwan, T. G., and J. Piesman.
2000.
Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice.
J. Clin. Microbiol.
38:382-388 |
| 46. |
Schwan, T. G.,
J. Piesman,
W. T. Golde,
M. C. Dolan, and P. A. Rosa.
1995.
Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.
Proc. Natl. Acad. Sci. USA
92:2909-2913 |
| 47. |
Shang, E. S.,
J. T. Skare,
M. M. Exner,
D. R. Blanco,
B. L. Kagan,
J. N. Miller, and M. A. Lovett.
1998.
Isolation and characterization of the outer membrane of Borrelia hermsii.
Infect. Immun.
66:1082-1091 |
| 48. |
Simpson, W. J.,
C. F. Garon, and T. G. Schwan.
1990.
Borrelia burgdorferi contains repeated DNA sequences that are species specific and plasmid associated.
Infect. Immun.
58:847-853 |
| 49. | Sonenshine, D. E. 1991. Biology of ticks, vol. 1. Oxford University Press, New York, N.Y. |
| 50. |
Stevenson, B.,
J. L. Bono,
T. G. Schwan, and P. Rosa.
1998.
Borrelia burgdorferi Erp proteins are immunogenic in mammals infected by tick bite, and their synthesis is inducible in cultured bacteria.
Infect. Immun.
66:2648-2654 |
| 51. |
Stevenson, B.,
S. Casjens, and P. Rosa.
1998.
Evidence of past recombination events among the genes encoding the Erp antigens of Borrelia burgdorferi.
Microbiology
144:1869-1879 |
| 52. |
Stevenson, B.,
S. Casjens,
R. van Vugt,
S. F. Porcella,
K. Tilly,
J. L. Bono, and P. Rosa.
1997.
Characterization of cp18, a naturally truncated member of the cp32 family of Borrelia burgdorferi plasmids.
J. Bacteriol.
179:4285-4291 |
| 53. | Stevenson, B., T. G. Schwan, and P. A. Rosa. 1995. Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 63:4535-4539[Abstract]. |
| 54. |
Stevenson, B.,
K. Tilly, and P. A. Rosa.
1996.
A family of genes located on four separate 32-kilobase circular plasmids in Borrelia burgdorferi B31.
J. Bacteriol.
178:3508-3516 |
| 55. |
Stoenner, H. G.,
T. Dodd, and C. Larsen.
1982.
Antigenic variation in B. hermsii.
J. Exp. Med.
156:1297-1311 |
| 56. |
Suk, K.,
S. Das,
W. Sun,
B. Jwang,
S. W. Barthold,
R. A. Flavell, and E. Fikrig.
1995.
Borrelia burgdorferi genes selectively expressed in the infected host.
Proc. Natl. Acad. Sci. USA
92:4269-4273 |
| 57. |
Thompson, R. S.,
W. Burgdorfer,
R. Russell, and B. J. Francis.
1969.
Outbreak of tick-borne relapsing fever in Spokane County, Washington.
JAMA
210:1045-1050 |
| 58. | Wallich, R., C. Brenner, M. D. Kramer, and M. M. Simon. 1995. Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo. Infect. Immun. 63:3327-3335[Abstract]. |
| 59. |
Wilske, B.,
V. Preac-Mursic,
S. Jauris,
A. Hofmann,
I. Pradel,
E. Soutschek,
E. Schwab,
G. Will, and G. Wanner.
1993.
Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi.
Infect. Immun.
61:2182-2191 |
| 60. | Xu, Y., and R. C. Johnson. 1995. Analysis and comparison of plasmid profiles of Borrelia burgdorferi sensu lato strains. J. Clin. Microbiol. 33:2679-2685[Abstract]. |
| 61. |
Yang, X.,
T. G. Popova,
K. E. Hagman,
S. K. Wikel,
G. B. Schoeler,
M. J. Caimano,
J. D. Radolf, and M. V. Norgard.
1999.
Identification, characterization, and expression of three new members of the Borrelia burgdorferi Mlp (2.9) lipoprotein gene family.
Infect. Immun.
67:6008-6018 |
| 62. | Zhang, J.-R., J. M. Hardham, A. G. Barbour, and S. J. Norris. 1997. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89:1-20[CrossRef][Medline]. |
| 63. |
Zückert, W. R., and J. Meyer.
1996.
Circular and linear plasmids of Lyme disease spirochetes have extensive homology: characterization of a repeated DNA element.
J. Bacteriol.
178:2287-2298 |
| 64. |
Zückert, W. R.,
J. Meyer, and A. G. Barbour.
1999.
Comparative analysis and immunological characterization of the Borrelia Bdr protein family.
Infect. Immun.
67:3257-3266 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»